A possible mechanism of low molecular weight protein tyrosine phosphatase (LMW-PTP) activity modulation by glutathione action during human osteoblast differentiation

Archives of Oral Biology

Volumn 54, Issue 7, 2009, Pages 642-650

  de Souza Malaspina, Tatiana Salles ^a   Zambuzzi, Willian Fernando ^b   dos Santos, Célio Xavier ^a   Campanelli, Ana Paula ^a   Laurindo, Francisco Rafael Martins ^a   Sogayar, Mari Cleide ^a   Granjeiro, José Mauro ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Low molecular weight protein tyrosine phosphatase; Osteoblast differentiation; Oxidized glutathione; Reduced glutathione

Indexed keywords

EID: 67349271034     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2009.03.011     Document Type: Article

References (41)

1. Park B.W., Hah Y.S., Kim D.R., Kim J.R., and Byun J.H. Osteogenic phenotypes and mineralization of cultured human periosteal-derived cells. Arch Oral Biol 52 (2007) 983-989
2. Takamori E.R., Cruz R., Goncalvez F., Zanetti R.V., Zanetti A., and Granjeiro J.M. Effect of roughness of zirconia and titanium on fibroblast adhesion. Artif Organs 32 (2008) 305-309
3. Chiarugi P., Taddei M.L., Schiavone N., Papucci L., Giannoni E., Fiaschi T., et al. LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 23 (2004) 3905-3914
4. Ramponi G., and Stefani M. Structural, catalytic, and functional properties of low M(r), phosphotyrosine protein phosphatases. Evidence of a long evolutionary history. Int J Biochem Cell Biol 29 (1997) 279-292
5. Chiarugi P. The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life 52 (2001) 55-59
6. Raugei G., Ramponi G., and Chiarugi P. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci 59 (2002) 941-949
7. Chiarugi P., Fiaschi T., Taddei M.L., Talini D., Giannoni E., Raugei G., et al. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276 (2001) 33478-33487
8. 2. J Biol Chem 273 (1998) 32554-32560
9. Tabernero L., Aricescu A.R., Jones E.Y., and Szedlacsek S.E. Protein tyrosine phosphatases: structure-function relationships. FEBS J 275 (2008) 867-882
10. Cirri P., Chiarugi P., Camici G., Manao G., Raugei G., Cappugi G., et al. The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. Eur J Biochem 214 (1993) 647-657
11. Cirri P., Chiarugi P., Taddei L., Raugei G., Camici G., Manao G., et al. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. J Biol Chem 273 (1998) 32522-32527
12. Ruggiero M., Pazzagli C., Rigacci S., Magnelli L., Raugei G., Berti A., et al. Negative growth control by a novel low M(r) phosphotyrosine protein phosphatase in normal and transformed cells. FEBS Lett 326 (1993) 294-298
13. Lucentini L., Fulle S., Ricciolini C., Lancioni H., and Panara F. Low molecular weight phosphotyrosine protein phosphatase from PC12 cells. Purification, some properties and expression during neurogenesis in vitro and in vivo. Int J Biochem Cell Biol 35 (2003) 1378-1387
14. Fiaschi T., Chiarugi P., Buricchi F., Giannoni E., Taddei M.L., Talini D., et al. Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. J Biol Chem 276 (2001) 49156-49163
15. Chiarugi P., Cirri P., Marra F., Raugei G., Fiaschi T., Camici G., et al. The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling. J Biol Chem 273 (1998) 6776-6785
16. Ferreira C.V., Justo G.Z., Souza A.C., Queiroz K.C., Zambuzzi W.F., Aoyama H., et al. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives. Biochimie 88 (2006) 1859-1873
17. Zambuzzi W.F., Yano C.L., Cavagis A.D., Peppelenbosch M.P., Granjeiro J.M., and Ferreira C.V. Ascorbate-induced osteoblast differentiation recruits distinct MMP-inhibitors: RECK and TIMP-2. Mol Cell Biochem 322 (2009) 143-150
18. Subramaniam M., Jalal S.M., Rickard D.J., Harris S.A., Bolander M.E., and Spelsberg T.C. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridisation. J Cell Biochem 87 (2002) 9-15
19. Lau K.H., and Baylink D.J. Osteoblastic tartrate-resistant acid phosphatase: its potential role in the molecular mechanism of osteogenic action of fluoride. J Bone Miner Res. 18 (2003) 1897-1900
20. Brasaemle D.L., and Attie A.D. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques 6 (1988) 418-419
21. Granjeiro J.M., Taga E.M., and Aoyama H. Purification and characterization of a low-molecular-weight bovine kidney acid phosphatase. Ann Acad Bras Cienc 69 (1997) 451-460
22. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48 (1972) 422-427
23. Declercq H., Van den Vreken N., De Maeyer E., Verbeeck R., Schacht E., De Ridder L., et al. Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: comparison of different isolation techniques and source. Biomaterials 25 (2004) 757-768
24. Hiraku Y., Murata M., and Kawanishi S. Determination of intracellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay. Biochim Biophys Acta 1570 (2002) 47-52
25. Akerboom T.P., and Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 77 (1981) 373-382
26. Harris S.A., Enger R.J., Riggs B.L., and Spelsberg T.C. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10 (1995) 178-186
27. Coelho M.J., and Fernandes M.H. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21 (2000) 1095-1102
28. Coelho M.J., Cabral A.T., and Fernande M.H. Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in alpha-MEM and in DMEM. Biomaterials 21 (2000) 1087-1094
29. Spelsberg T.C., Harris S.A., and Riggs B.L. Immortalized osteoblast cell systems (new human fetal osteoblast systems). Calcified Tissue Int 56 (1995) S18-21
30. Li Z., Zhou Z., Saunders M.M., and Donahue H.J. Modulation of connexin43 alters expression of osteoblastic differentiation markers. Am J Physiol Cell Physiol 290 (2006) C1248-C1255
31. Ignatius A., Blessing H., Liedert A., Schmidt C., Neidlinger-Wilke C., Kaspar D., et al. Tissue engineering of bone: effects of mechanical strain on osteoblastic cells in type I collagen matrices. Biomaterials 26 (2005) 311-318
32. Hsu Y.L., and Kuo P.L. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. J Bone Miner Res 23 (2008) 949-960
33. Maniatopoulos C., Sodek J., and Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254 (1988) 317-330
34. Kaur G., Valarmathi M.T., Potts J.D., and Wang Q. The promotion of osteoblastic differentiation of rat bone marrow stromal cells by a polyvalent plant mosaic virus. Biomaterials 29 (2008) 4074-4081
35. Mourey R.J., Vega Q.C., Campbell J.S., Wenderoth M.P., Hauschka S.D., Krebs E.G., et al. A novel cytoplasmic dual specificity protein tyrosine phosphatase implicated in muscle and neuronal differentiation. J Biol Chem 271 (1996) 3795-3802
36. Chiarugi P., Cirri P., Taddei L., Giannoni E., Camici G., Manao G., et al. The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 275 (2000) 4640-4646
37. Ostman A., Yang Q., and Tonks N.K. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 91 (1994) 9680-9684
38. Ning J., and Grant M.H. The role of reduced glutathione and glutathione reductase in the cytotoxicity of chromium (VI) in osteoblasts. Toxicol In Vitro 14 (2000) 329-335
39. Pani G., Colavitti R., Bedogni B., Anzevino R., Borrello S., and Galeotti T. A redox signaling mechanism for density-dependent inhibition of cell growth. J Biol Chem 275 (2000) 38891-38899
40. Chiarugi P., Pani G., Giannoni E., Taddei L., Colavitti R., Raugei G., et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161 (2003) 933-944
41. de Souza Malaspina T.S., dos Santos C.X., Campanelli A.P., Laurindo F.R., Sogayar M.C., and Granjeiro J.M. Tartrate-resistant acid phosphatase activity and glutathione levels are modulated during hFOB 1.19 osteoblastic differentiation. J Mol Histol 39 (2008) 627-634